8 results
diagnosis erythematosus systemic ana antinuclear hematology patterns syndrome testing apml differentiation druginduced drugs hemeonc heparin hit holistic induced medications nuclear
Antinuclear Antibody Testing - Nuclear and Cytoplasmic Patterns Nuclear Patterns: • Homogeneous pattern: -
Antinuclear Antibody ... - Nuclear and Cytoplasmic ... #Antinuclear #Antibody ... #Patterns #differential ... #diagnosis #rheumatology
Antinuclear Antibody Testing Cytoplasmic Patterns Reticular/AMA: • PBC, SSc, PBC/SSc OS, PBC/SjS OS • AMA Speckled: •
Antinuclear Antibody ... Testing Cytoplasmic ... #Testing #Cytoplasmic ... #Patterns #differential ... #diagnosis #rheumatology
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
SLE (Systemic Lupus ... permanent alopecia Differential ... Non-autoimmune rheumatologic ... Thrombosis highest risk ... Erythematosus #Diagnosis #Rheumatology
Drug Induced Systemic Lupus Erythematosus > 100 drugs have been associated with drug-induced SLE High risk (>5%): •
Induced Systemic Lupus ... for 1 year of treatment ... medications #drugs #pharmacology ... #risk #differential ... #diagnosis #rheumatology
Holistic Management of Systemic Lupus • Lifestyle interventions: Smoking cessation, Photoprotection, Therapeutic adherence, Anxiety/depression/fatigue, Fibromyagia/pain management,
of Systemic Lupus ... Cardiovascular risk ... #holistic #SLE ... #Systemic #Lupus ... #treatment #rheumatology
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook Presentation: • Plts ↓50% (nadir
injection sites) ↑ Risk ... heparin-PF4 complex → plt ... hypercoagulable state and plt ... Confirmatory test ↑Se ... #Treatment #Hematology
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Attempt if high risk ... initiation • Differential ... fluid overload, PCC ... APML #diagnosis #management
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
No results found for "PLC differential management treatment rheumatology sle pharmacology antibody lupus cytoplasmic risk"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PLC #differential #management #treatment #rheumatology #sle #pharmacology #antibody #lupus #cytoplasmic #risk